Ledger.Open graph →
SEC Form D · filed January 27, 2025

SYNTIS BIO, INC

Offering
$9.0M
Sold
$6.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Boston, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Robert Langer · Boston, MADirectorCarlo Giovanni Traverso · Boston, MADirectorMartin Madaus · Boston, MADirectorRahul Dhanda · Boston, MAExec · DirectorTeymour Boutros-Ghali · Boston, MADirectorRahul Dhanda · Boston, MAExec · DirectorTeymour Boutros-Ghali · Boston, MADirectorRobert Langer · Boston, MADirectorMartin Madaus · Boston, MADirectorCarlo Giovanni Traverso · Boston, MADirectorAlfred Lin · New York, NYDirectorAlison Brown · Salt Lake City, UTExec · DirectorBrad Holden · San Francisco, CADirectorMehul Shah · San Jose, CADirectorPaul Sigfusson · Tampa, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗